A Study of Safety and Efficacy of UNR844 Chloride (UNR844-Cl) Eye Drops in Subjects With Presbyopia.

Completed · Phase 2 · Has a placebo group

Conditions studied: Presbyopia

In brief

The purpose of this study was to assess the effect of topical UNR844-Cl (lipoic acid choline ester chloride) ophthalmic solution on near visual function in presbyopic subjects.

Key facts

Study ID
NCT03809611
Run by
Novartis Pharmaceuticals
People needed
125
Starts
2019-04-26
Expected to finish
2019-12-16
Last updated by the study team
2022-05-11

Who can join

Age: 45 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.